<p><strong></strong></p><p><strong> Category III code 1139T becomes effective January 1, 2027, giving U.S. physicians and hospitals a dedicated procedure code to report AI ECG analysis for heart attacks </strong></p><p></p><p>NEW YORK--(BUSINESS WIRE)--October 27, 2026--</p><p> <b>Powerful Medical, a leader in AI-driven cardiovascular diagnostics, today announced that the American Medical Association (AMA) CPT® Editorial Panel has established a new Category III CPT code, 1139T, for the noninvasive identification of ST-elevation myocardial infarction (STEMI), STEMI equivalents, and acute or subacute myocardial ischemia by assistive algorithmic analysis of the electrocardiogram (ECG). This is the service performed with Queen of Hearts™, which received FDA De Novo authorization in September 2026. The code takes effect on January 1, 2027.</b> </p><p id="news-body-cta">This press release features multimedia. View the full release here: <a href="https://www.businesswire.com/news/home/20261027207205/en/" rel="nofollow">https://www.businesswire.com/news/home/20261027207205/en/</a></p><div id="bwbodyimg" style="width: 480px; float:left; padding-left:0px; padding-right:20px; padding-top:0px; padding-bottom:0px;"><img src="https://mms.businesswire.com/media/20261027207205/en/2947296/4/Business_Wire_%E2%80%94_2400%C3%971600_%283_2%29_%C2%B7_light%401x.jpg" alt="New Category III CPT® code 1139T, effective January 1, 2027, covers AI ECG identification of acute MI, the service performed by Powerful Medical’s Queen of Hearts™."><p style="font-size:85%;">New Category III CPT® code 1139T, effective January 1, 2027, covers AI ECG identification of acute MI, the service performed by Powerful Medical’s Queen of Hearts™.</p></div><p> CPT codes are the common language U.S. physicians and hospitals use to report medical services. The new code opens the path to coverage and reimbursement for AI ECG heart attack detection. From January 1, 2027, physicians and hospitals will have a standard way to report the service, and the resulting claims data is what Medicare and commercial payers use when making coverage and payment decisions. Code 1139T is reported in addition to the standard 12-lead ECG codes (93000, 93005, 93010). </p><p> “In September, the FDA authorized Queen of Hearts. From January, U.S. hospitals and physicians will have a dedicated code to report the work it does,” said <b>Felix Bauer</b>, COO and Co-founder of Powerful Medical. “A CPT code is the first step toward coverage and reimbursement, and we are actively working to secure the relevant reimbursement pathways to support adoption across the United States.” </p><p> Someone in the United States has a heart attack every 40 seconds, yet up to four in ten acute coronary occlusions do not show the classic ST-elevation pattern that standard ECG criteria rely on. These STEMI equivalents are hard to identify on the first ECG, and treatment can be delayed. </p><p> "S<i>TEMI equivalents are the heart attacks standard ECG criteria were never designed to find</i>,” said <b>Robert Herman, MD, PhD</b>, Chief Medical Officer and Co-founder of Powerful Medical. “<i>Seeing them written into the CPT code set matters to every emergency physician and cardiologist who has watched one of these patients wait.</i>” </p><p> Queen of Hearts™ received FDA Breakthrough Device Designation and, in September 2026, De Novo authorization, establishing a new device classification for acute cardiovascular event detection and notification software (21 CFR 870.2390). The technology is backed by more than 20 peer-reviewed studies, including randomized controlled trials, spanning over 40,000 patients across four continents. It helps healthcare professionals identify patients with suspected acute coronary syndrome (ACS) who benefit from urgent cardiologist activation and potentially early cardiac catheterization. </p><p> Queen of Hearts™ is now available to U.S. hospitals through the PMcardio for Organizations platform, which integrates with existing hospital IT infrastructure. For more information, visit <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=http%3A%2F%2Fwww.powerfulmedical.com&amp;esheet=54629110&amp;newsitemid=20261027207205&amp;lan=en-US&amp;anchor=www.powerfulmedical.com&amp;index=1&amp;md5=bcc819d2a8778a2b548f18c07ebe7efc" shape="rect">www.powerfulmedical.com</a>. </p><p> <b>About Powerful Medical</b> </p><p> Powerful Medical is leading the AI revolution in cardiology, making expert-level cardiac diagnosis available to every patient, regardless of where they present. Its platform, PMcardio, embeds AI ECG models that detect acute heart attacks (Queen of Hearts™, FDA-authorized and CE-marked) and, in the EU, heart failure, structural heart disease, and 40+ other cardiac conditions. PMcardio is used by more than 100,000 clinicians across hospitals, EMS, and cardiac centers worldwide. </p><p><img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20261027207205r1&amp;sid=ventb&amp;distro=nx&amp;lang=en" style="width:0;height:0"><span class="bwct31415"></span></p><p id="mmgallerylink"><span id="mmgallerylink-phrase">View source version on businesswire.com: </span><span id="mmgallerylink-link"><a href="https://www.businesswire.com/news/home/20261027207205/en/" rel="nofollow">https://www.businesswire.com/news/home/20261027207205/en/</a></span></p><p> <b>Media contact </b><br>Powerful Medical: <a rel="nofollow" href="mailto:pr@powerfulmedical.com" shape="rect">pr@powerfulmedical.com</a> </p>

<p>SAN FRANCISCO--(BUSINESS WIRE)--October 27, 2026--</p><p> <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Flistenlabs.ai%2F&amp;esheet=54628027&amp;newsitemid=20261027373375&amp;lan=en-US&amp;anchor=Listen+Labs&amp;index=1&amp;md5=0fd2303114b97267997f84f604a4f216" shape="rect">Listen Labs</a>, the AI platform for customer understanding, launched <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Flistenlabs.ai%2Ftwins&amp;esheet=54628027&amp;newsitemid=20261027373375&amp;lan=en-US&amp;anchor=Listen+Twins&amp;index=2&amp;md5=85cd39c8391adf82486eae81f4177b4a" shape="rect">Listen Twins</a>, one-to-one AI models of real people in a company’s target audience. Each Twin is built from an in-depth interview and can predict what that person will do and why. Companies can ask their own panel of 100+ Twins a question and see how their audience would respond in seconds. </p><p> Every Listen Twin is based on one real person and purpose-built for each team’s use cases. In testing, Twin answers matched the distribution of real people’s answers with 93% accuracy. </p><p> <b>How it works</b> </p><p> Teams define their target audience and the decisions they want to inform. Listen Labs recruits matching participants from its network of more than 50 million people, interviews each one in depth, and builds their Twin. Each model is also enriched with a company’s existing customer, persona, and past study data. </p><p> Across an organization, teams can ask their Twins any question. Each Twin answers with its reasoning, the real interview quote behind it, and a confidence score. It won’t guess beyond its scope. </p><p> Listen Twins inform business questions every day, such as: </p><ul class="bwlistdisc"> <li> <b>Which campaign concept should we run?</b> Marketing teams compare campaign directions and see which segments respond to each, and why. Day to day, the same teams test messaging, creative, copy, and ad variants. </li> </ul><ul class="bwlistdisc"> <li> <b>How will people react to our announcement?</b> Comms teams find the content that lands wrong and update the story before the news goes out. </li> </ul><ul class="bwlistdisc"> <li> <b>What would customers pay more for?</b> Product teams identify which features would justify a higher price, and which ones customers already expect, to prioritize their roadmap. </li> </ul><ul class="bwlistdisc"> <li> <b>Should we enter this market? </b>Strategy teams research how people in another country respond, and what needs to change before launch. </li> </ul><p> For higher stakes go/no-go decisions, Listen Labs continues to recommend a full research study using its AI-moderation product. </p><p> “Our Twins know the story behind every answer. And across millions of interviews, we have identified Keystone Questions that unlock how people actually behave. The ability to predict how people will react is a powerful tool. So we’re building this responsibly.” <b>- Alfred Wahlforss, Co-Founder and CEO, Listen Labs</b> </p><p> Learn more at <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Flistenlabs.ai%2Ftwins&amp;esheet=54628027&amp;newsitemid=20261027373375&amp;lan=en-US&amp;anchor=listenlabs.ai%2Ftwins&amp;index=3&amp;md5=7f0d181db9c36629435a9843f90e2ef6" shape="rect">listenlabs.ai/twins</a>. </p><p> <b>About Listen Labs</b> </p><p> Listen Labs is the end-to-end AI platform for customer understanding. Listen Labs studies show companies what their customers think, why they think it, and what to do about it. The company has run more than 2 million AI-powered interviews across a global network of 50+ million participants, and its 130-person team includes a full bench of in-house researchers and insights professionals. Listen Labs has raised $100 million to date, including a Series A led by Sequoia Capital and a $69 million Series B led by Ribbit Capital, and works with companies from high-growth startups to global enterprises, including Anthropic, Microsoft, and Chubbies. Learn more at <a rel="nofollow" href="https://cts.businesswire.com/ct/CT?id=smartlink&amp;url=https%3A%2F%2Flistenlabs.ai&amp;esheet=54628027&amp;newsitemid=20261027373375&amp;lan=en-US&amp;anchor=listenlabs.ai&amp;index=4&amp;md5=2bc4451c83c797e0d63263ea81b6e05b" shape="rect">listenlabs.ai</a>. </p><p><img alt="" src="https://cts.businesswire.com/ct/CT?id=bwnews&amp;sty=20261027373375r1&amp;sid=ventb&amp;distro=nx&amp;lang=en" style="width:0;height:0"><span class="bwct31415"></span></p><p id="mmgallerylink"><span id="mmgallerylink-phrase">View source version on businesswire.com: </span><span id="mmgallerylink-link"><a href="https://www.businesswire.com/news/home/20261027373375/en/" rel="nofollow">https://www.businesswire.com/news/home/20261027373375/en/</a></span></p><p> <b>Media contact </b><br><a rel="nofollow" href="mailto:press@listenlabs.ai" shape="rect">press@listenlabs.ai</a> </p>

Today is my last day as Editorial Director at VentureBeat.